Indications for ACTH and Cortisone in Rheumatoid Arthritis
By J. J. R. DUTHIE, F.R.C.P.Ed.
IN the treatment of rheumatoid arthritis much has been learnt during the last four years of the contra-indications to the use of cortisone or ACTH, but indications for their administration remain very much a matter of personal opinion. However, certain aspects of the problem can now be discussed with greater confidence as a result of experience gained during this period:
(1) It has become apparent that improvement in function in rheumatoid arthritis is due to a suppression of the inflammatory reaction in connective tissues.-This effect is in po way specific. The inflammatory reaction to tissue injury can be profoundly modified by the adrenal steroids irrespective of the nature of the damaging agent. This has been demonstrated in a large variety of circumstances, both in experimental animals and in human disease.
(2) There is no satisfactory evidence, as yet, that rheumatoid arthritis is due, directly or indirectly, to any abnormality in function of the pituitary-adrenal axis or to the production of abnormal steroid hormones by the adrenal gland itself.
(3) The natural course of the disease does not appear to be significantly altered in the majority of cases even by prolonged administration of either hormone.
(4) It has become abundantly clear that the continuous administration of either ACTH or cortisone, in doses sufficient to achieve complete suppression of symptoms, is impractical because of the high incidence of serious side-effects.
(5) Dose requirements may vary in the individual patient, presumably as a result of fluctuations in the activity of the underlying disease process. There is no guarantee that in a particular patient symptoms will continue to be controlled satisfactorily by a dose which proved adequate and safe in the initial stages of treatment.
(6) If treatment has to be withdrawn for any reason, not only may the symptoms of the disease recur in a severe form, but the "cortisone withdrawal syndrome" may develop-a condition characterized by exhaustion, profound weakness, anorexia, weight loss, mental depression and generalized muscular and joint pain.
(7) Experience has shown that in certain circumstances, prolonged administration of either cortisone or ACTH may be specifically contra-indicated. For example, in tuberculosis, spread of the disease is facilitated presumably by inhibition of the inflammatory reaction in tissues invaded by the organism. Quiescent lesions may become active. In infections other than tuberculosis a similar effect has been observed. The signs of intercurrent infections may be masked. In patients with a history of dyspepsia, massive haemorrhage from peptic ulcers has occurred. Previously unsuspected ulcers have perforated. In the presence of heart disease, renal disease or hypertension, the blood pressure may rise to dangerous levels, signs of cardiac failure may appear or, if already present, become more severe. Acute psychosis may occur, especially in patients with a previous history of emotional instability. In diabetic patients, insulin requirements are markedly increased by cortisone or ACTH, and in a few instances diabetes has developed during treatment and has persisted after the hormone has been withdrawn. When the disease process has given rise to osteoporosis, hormone therapy may accentuate this condition and fractures of the long bones or collapse Qf a vertebral body may result. This complication occurs most commonly in post-menopausal women.
From what has been said it becomes apparent that a significant number of patients suffering from rheumatoid arthritis should not be given cortisone or ACTH because of the co-existence of conditions which increase the risk of dangerous complications. This will apply particularly to elderly patients and more particularly to women. As the average age of onset of rheumatoid arthritis is around 40, and women are affected by the disease at least twice as often as men, these limiting factors are important.
These are the main lessons learnt from experience during the last four years. It must be accepted that these hormones have no curative value and must be given continuously if their effect on symptoms is to be maintained. Rheumatoid arthritis is an incurable disease and its ultimate course is not materially altered by hormone treatment. The risk of serious side-effects increases the longer treatment is continued, although our experience to date is relatively limited. Complications become more common with increasing age. In the majority of series reported up to the present time, the duration of observation has been limited to two to three years, and a significant number of cases have terminated treatment for one reason or another. Is it likely that a worth-while number of patients will be able to continue on these hormones throughout life on a dose which is safe and at the same time effective? The results of a trial reported recently by West and Newns (1953) do not support this view. Even if good control of symptoms can be maintained indefinitely by a safe dose, what is the ultimate effect likely to be?
If the assumption is correct that the underlying disease process is unaltered and only the symptoms of tissue damage are suppressed, the wisdom of such continuous suppression is doubtful, even in patients who remain free from all complications and side-effects. Cortisone and ACTH are relatively ineffective in controlling the pain and disability which arise from irreversible damage to joints. Suppression of reactionary inflammation may, by allowing greater functional use, lead to an increase in damage of this nature. This is speculative, but the possibility requires serious consideration in reaching a decision on the ethics of continuous maintenance treatment even in those patients where this is practical.
If the dose of cortisone is kept below 100 mg. daily side-effects and complications are less common, although at this level only partial control ofsymptoms can be attained in the majority ofcases. However, it may be argued that partial suppression of symptoms at a safe dose level is the proper compromise, giving worth-while improvement in function without entirely suppressing the symptoms which will warn the patient against over-use of damaged joints. Such a use of cortisone would be justified if it could be shown that no cheaper and safer method of treatment produced equally good results.
A clinical trial being conducted at the present time under the auspices of the Medical Research Council and the Nuffield Foundation has been designed to compare the effects of the long-term administration of aspirin and cortisone in comparable groups of patients suffering from rheumatoid arthritis. From a preliminary report it may be stated that the results in the two groups at the end of the first three months differed statistically only in respect oftwo features ofthe disease. In the cortisonetreated group the E.S.R. was significantly lower and the hemoglobin significantly higher, but on the basis of the other objective measurements-strength of grip, joint tenderness and range of movement, the time taken to walk a fixed distance or climb a number of stairs, and a general overall assessment of functional status-no significant difference was found. West and Newns (1953) have recently reported the results of a trial designed to provide an answer to the question whether oral administration of cortisone acetate in doses between 50 and 75 mg. daily and continued over a long period favourably affects the course of rheumatoid disease or not. The average duration of treatment at the time of publication was nineteen months. Only one patient on cortisone was able to dispense with aspirin entirely. The average requirements of the treated patients was 8 aspirin tablets daily. The results in the group receiving cortisone were compared with a group treated by other methods. No significant difference between the two groups was found. The conclusion was reached that long-continued adinnistration of cortisone to patients suffering from rheumatoid arthritis was not to be recommended until complications which cannot be foreseen or prevented at present can be avoided with certainty. From these studies and others in progress it would appear that even if all patients with definite contra-indications to the use of cortisone and ACTH are excluded and the dose of cortisone is kept below 100 mg. daily, complications of a serious nature may still occur. More striking, however, is the observation that the results obtained by the continuous administration of cortisone are apparently no better in the long run that those which follow the combination of full doses of aspirin with a sound basic regime of treatment.
If this review of the lessons learnt during the last four years has been fair and impartial, it would appear that the use of continuous maintenance treatment with ACTH or cortisone in cases of rheumatoid arthritis is not justified in the light of our present knowledge.
Can these hormones be applied to any aspect of the treatment of rheumatoid arthritis, even if their continuous administration is best avoided? In cases running a severe downhill course, where all other forms of treatment have failed to control the disease and where crippling deformities cannot be prevented by conservative methods, the short-term use of cortisone, or preferably ACTH, in the powerful long-acting form now available, may be justified. In such instances high doses should be used initially to control the inflammatorv component of the disease and allow deformities to be corrected. These may be largely due to muscie spasm in the earlier stages of the disease and correction may be achieved relatively rapidly by the use of serial plasters when pain and spasm have been abolished. Such a course of treatment must be supplemented by appropriate physiotherapy and exercises to consolidate the gain. When these specific objectives have been attained, the dose of hormone should be reduced gradually and maximum tolerable doses of aspirin prescribed. The purpose of treatment by this method must be made clear to the patient at the outset and due warning given of the likely recurrence of symptoms during the withdrawal period. The application of this method must obviously be limited to severe cases in the early stages of the disease, before irreversible damage has become extensive, and in the absence of specific contra-indications to the use of ACTH or cortisone. The use of ACTH or cortisone to provide cover for orthopedic procedures in rheumatoid patients has been advocated. Experience in this country has been less favourable than that reported from America, and judgment on the value of hormone cover for operations and manipulations must be reserved in the meantime.
During the last year experience has been gained in this country which confirms the favourable reports from the States on the use of hydrocortisone for intra-articular injection. The action is purely local an I apparently free from undesirable complications. Relief from pain and improvnmeit in function 3249 Section of Mediine 325 lasting from a few days to several weeks or even months may follow a single injection of 50 mg.
Injections can be repeated without loss of effect. This method is likely to find a useful place in the treatment of rheumatoid arthritis when supplies of hydrocortisone become more plentiful. It is particularly applicable in patients incapacitated by pain and stiffness in a single weight-bearing joint.
The best results have been obtained in the treatment of the knee. CONCLUSIONS It is my personal opinion that, in the light of our present knowledge and experience, there is no indication for the treatment of rheumatoid arthritis by the continuous administration of ACTH or cortisone. The use of short courses of either hormone, but preferably ACTH, may be justified in severe and progressive cases where conservative measures have failed to control the disease process and where severe crippledom is likely.
The local use of hydrocortisone in the treatment of single joints is likely to be accepted as a useful method of treatment, free from complications and giving worth-while relief of symptoms in a significant number.
The IF I may summarize the experience of long-term therapy gained by my group over the last three years, I would say that cortisone and ACTH, if used properly and intelligently, can be extremely helpful, and with care need not be dangerous. Long-term maintenance presents difficulties (as do many other forms of medical therapy), but these can, in most cases, be overcome if time and trouble are taken.
We agree that under cover of long-term suppression of the symptoms of the disease structural joint changes may slowly increase, but surely this is a normal clinical risk and worth facing, if thereby the patient can be given a significant extension of pain-free and useful working life. This we have been able to achieve in 17 out of the 20 cases constituting our present trial series.
To achieve such a result, however, suitable cases must be carefully selected (some cases in recently reported trials were both unselected and had irreversible crippling present before treatment was started); and to avoid "rebound" and "withdrawal" phenomena dosage must be very gradually "tailed off" if treatment is to be stopped for any reason.
The indications for the use of cortisone and ACTH as long-term treatment we would consider to be cases of rheumatoid arthritis in which structural damage is such that function is capable of being restored to a useful degree, and which have failed to react to classical methods of treatment. There must be none of the well-recognized contra-indications present, and the patient should, if possible, be intelligent and co-operative. The dose found to be needed for adequate maintenance must be reasonably low, so that the occurrence of serious side-effects is not likely.
Indications for short-term therapy in rheumatoid arthritis will generally be to "cover" some special procedure in rehabilitation, such as manipulation. In such cases dosage must be carefully regulated, and reduced slowly and progressively. [The intra-articular use of hydrocortisone lies outside this discussion but its use in this way can be of great additional help in many cases of rheumatoid arthritis where the rate of joint improvement under oral therapy is uneven. ] We feel that following the original scmewhat uncritical acceptance of steroid therapy, the recent fashionable trend is to decry the use of these hormones unduly for long-term therapy. Such criticism tends to be based on only one or two reports which happen to have achieved considerable publicity. These have over-emphasized the possible dangers and complications of cortisone therapy.
One's opinion of a remedy must depend upon what one expects of it, and Dr. Duthie and I approach the matter from different angles. He as a clinical scientist, with a somewhat "perfectionist" outlook; myself from the more old-fashioned outlook of the clinician who sees what looks like a useful therapeutic tool and tries to find out how best it can be used to benefit his patients, despite its acknowledged imperfections. Under cortisone therapy patients still retain their imperfect joints, still suffer periodical exacerbations, and in the long run the structural damage to their locomotor system may even slowly increase under cover of these hormones. Nevertheless they can with its help be shielded from the most unpleasant effects of the disease, and so made more active, useful and happy members of society long after this would have ceased to be possible without its help. No one, I think, has ever claimed cortisone to be a cure for rheumatoid arthritis. Unfortunately there is no real cure as yet. But many groups who have worked in this field, including my own, consider that if it is intelligently used it can be of great help in the management of this difficult disease. If we cannot find a real cure, any agent which is none the less capable of producing a major suppression of symptoms in suitable cases by virtue of an anti-inflammatory action, however non-specific, is worth looking into carefully, and learning how best it can be used.
In rheumatoid arthritis cortisone will initially reverse most of those pathological changes which still remain reversible, and suppress the activity of the disease. There can, therefore, only be two valid
